© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Lexicon Pharmaceuticals, Inc. (LXRX) shows an Average True Range (ATR) of 0.12 and an Enterprise Value of 477.58M. Its average trading volume over the past 3 months is 2.36M, indicating liquidity. These fundamental metrics provide insight into LXRX's underlying financial health and market activity.
| ATR | 0.12 |
| Enterprise Value | 477.58M |
| Avg Vol (3 Months) | 2.36M |
| Avg Vol (10 Days) | 1.42M |
Lexicon Pharmaceuticals, Inc. (LXRX) technical indicators as of May 2, 2026: the SMA 20 is 11.4%, SMA 50 at 14.43%, and SMA 200 at 27.48%. The RSI 14 value is 57.73, suggesting its current momentum. These technical analysis signals help assess LXRX's price trends and potential future movements.
| SMA 20 | 11.4% |
| SMA 50 | 14.43% |
| SMA 200 | 27.48% |
| RSI 14 | 57.73 |
Lexicon Pharmaceuticals, Inc. (LXRX) stock performance overview as of May 2, 2026: The 52-week high is $1.95 (currently -18.03% below), and the 52-week low is $0.514 (currently 428.91% above). Over the past year, LXRX's performance is 83.63%, compared to the S&P 500's 17.86% change.
| 52-Week High | 1.95 |
| 52-Week High Chg | -18.03% |
| 52-Week Low | 0.5137 |
| 52-Week Low Chg | +428.91% |
| S&P 500 52-Week Chg | 17.86% |
According to market data, Lexicon Pharmaceuticals, Inc. (LXRX) stock's recent performance metrics show that over the last month, LXRX is 13.91%, with a Year-to-Date (YTD) performance of 13.91%. Over the past year, the stock has seen a 83.63% change. These figures summarize LXRX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 1.86 | 1.95 | 1.95 | 1.95 | 1.95 | 1.95 |
| Low | 1.55 | 1.49 | 1.1 | 1.1 | 0.5137 | 1.1 |
| Performance | +11.02% | +13.91% | -7.75% | +6.50% | +83.63% | +13.91% |
According to current financial data, LXRX stock's P/E (TTM) ratio is -11.66, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for LXRX, including P/S (13.74), P/B (5.46), and P/FCF (-10.08), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | LXRX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -11.66 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | 13.74 | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 5.46 | -0.09 | 1.01 | 4.72 |
| P/FCF (TTM) | -10.08 | -191.12 | -462.17 | 32.8 |